Daily buyback report: 45,410 shares bought back on Sept 10, 2026

Corporate Actions View source PDF Explain this filing

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹302.20

prior close

₹303.35

announcement price

After-mkt

timing

Nifty Microcap 250market+0.1%-3.0% vs market

Biotechnology peers, median of 5sector+0.6%-3.4% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.4 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.6

10m

-1.7

15m

-1.4

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.9+0.1-3.0+0.6-3.4

Next day

-4.1-3.2-0.9+0.0-4.1

-5.0-3.3-1.7-2.4-2.6

-4.1-2.5-1.6-0.7-3.4

-4.5-0.9-3.6-1.2-3.4

-2.7-1.1-1.7-2.0-0.7

-1.6+0.6-2.2-4.0+2.4

15d

-9.6-1.4-8.2-4.6-5.0

-11.9-3.3-8.7-6.0-5.9

—————

UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advanced Enzyme Technologies bought back 45,410 equity shares on September 10, 2026 at an average price of rupees 303 per share, all purchased on NSE through broker Emkay Global Financial Services. This brings the cumulative total shares repurchased under the ongoing open market buyback to 11,88,150 equity shares. The buyback is being carried out through the stock exchange mechanism under SEBI Buyback Regulations, with a face value of rupees 2 per share.

Likely market impact

Routine daily buyback update; consistent open market purchases gradually reduce share count, mildly supportive of EPS over time.